Modified Extraction-Free Ion-Pair Methods for the Determination of Flunarizine Dihydrochloride in Bulk Drug, Tablets, and Human Urine
- 7 Downloads
Two simple and sensitive extraction-free spectrophotometric methods are described for the determination of flunarizine dihydrochloride. The methods are based on the ion-pair complex formation between the nitrogenous compound flunarizine (FNZ), converted from flunarizine dihydrochloride (FNH), and the acidic dye phenol red (PR), in which experimental variables were circumvented. The first method (method A) is based on the formation of a yellow-colored ion-pair complex (1:1 drug:dye) between FNZ and PR in chloroform, which is measured at 415 nm. In the second method (method B), the formed drug-dye ion-pair complex is treated with ethanolic potassium hydroxide in an ethanolic medium, and the resulting base form of the dye is measured at 580 nm. The stoichiometry of the formed ion-pair complex between the drug and dye (1:1) is determined by Job's continuous variations method, and the stability constant of the complex is also calculated. These methods quantify FNZ over the concentration ranges 5.0–70.0 in method A and 0.5–7.0 μg/mL in method B. The calculated molar absorptivities are 6.17 × 103 and 5.5 × 104 L/mol·cm–1 for method A and method B, respectively, with corresponding Sandell sensitivity values of 0.0655 and 0.0074 μg/cm2. The methods are applied to the determination of FNZ in pure drug and human urine.
Keywordsextraction-free ion-pair complex phenol red flunarizine pharmaceutical formulation human urine
Unable to display preview. Download preview PDF.
- 2.M. R. Alan, D. S. Fred, and J. T. Stewart, Conquering Headache, 4th edn., Decker DTC, Hamilton, London (2003).Google Scholar
- 3.European Pharmacopoeia, Vol. II, European Department for the Quality of Medicines, Council of Europe, Stranbourg, France (2005).Google Scholar
- 4.British Pharmacopoeia, Vol. II, Her Majesty's Stationary Office, London (2009).Google Scholar
- 8.M. Abdul-Azim Mohammad, Bull Fac. Pharm. Cairo Univ., 42, 27 (2004).Google Scholar
- 9.S. A. Patil, A. A. Shirkhedkar, J. S. Surana, and S. P. Nawale, Pharma Chem., 3, 404 (2011).Google Scholar
- 10.A. K. Doshi, B. N. Patel, and C. N. Patel, Int. J. Pharm. Sci. Res., 3, 1741 (2012).Google Scholar
- 12.V. S. S. P. Adapa, C. Ravi, C. S. P. Sastry, and U. V. Prasad, Acta Cienc. Indica, Chem., 27, 105 (2001).Google Scholar
- 14.M. Y. El-Maamli, Egypt. J. Biomed. Sci., 11, 122 (2003).Google Scholar
- 16.M. J. Badalani, K. R. Mahadik, H. N. More, and S. S. Kadam, East Pharm., 38, 133 (1995).Google Scholar
- 17.M. S. Elazazy, M. El-Mammli, A. Shalaby, and M. A. Magda, Biosci., Biotechnol. Res. Asia, 5, 107 (2008).Google Scholar
- 18.V. S. S. P. Adapa, G. P. V. Mallikarjuna Rao, C. S. P. Sastry, and U. V. Prasad, J. Ind. Council Chem., 18, 36 (2001).Google Scholar
- 19.S. S. Zarapkar and R. K. Bapat, Indian Drugs, 31, 170 (1994).Google Scholar
- 22.K. N. Prashanth, K. Basavaiah, and M. S. Raghu, Chem. Sci. J., 80, 1–14 (2012).Google Scholar
- 23.K. N. Prashanth, K. Basavaiah, and K. B. Vinay, Arab. J. Chem. (2011); doi: https://doi.org/10.1016/j.arabjc.2011.10.006.
- 24.M. S. Raghu and K. Basavaiah, Proc. Natl. Acad. Sci., India A: Phys. Sci., 82, 187 (2012).Google Scholar
- 26.H. Zavis, D. Ludvik, K. Milan, S. Ladislaw, and V. Frantisck, Handbook of Organic Reagents in Inorganic Analysis, Chichester, A Division of John Wiley & Sons IC, New York, London, Sydney, Toronto (1976).Google Scholar
- 27.International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology, Q2 (R 1), Complementary Guideline on Methodology dated 06 November 1996, London, incorporated in November 2005.Google Scholar
- 28.J. Inczedy, T. Lengyel, and A. M. Ure, IUPAC Compendium of Analytical Nomenclature: Definitive Rules, Blackwell Science Inc., Boston (1998).Google Scholar